A new platform developed by researchers at the University of Texas MD Anderson Cancer Center quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells, even without knowing which tumor targets are recognized by the immune cells. This approach addresses a major bottleneck in immunotherapy development and could accelerate the creation of personalized treatments.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Rare stem T cells may hold the key to fighting chronic diseases | 5 | 7 | 01-07-2026 |
| 2 | Tumor on a chip reveals how pancreatic cancer hijacks immune cells in real time | 5 | 8 | 07-07-2026 |
| 3 | Ученые нашли способ создать источник клеток для борьбы с раком | 5 | 7 | 06-07-2026 |
| 4 | New blood test for noncoding RNA significantly improves cancer detection | 7 | 8 | 31-08-2023 |
| 5 | Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors | 2 | 8 | 20-07-2026 |
| 6 | Tumors hijack macrophages after they clear dead cells, real-time tracking reveals | 0 | 8 | 02-07-2026 |
| 7 | New study reveals how blood cancers outsmart BTK-targeted therapies | 0 | 8.1 | 28-07-2026 |
| 8 | Ученые смогут заранее оценивать эффективность иммунотерапии для больных раком по иммунным клеткам из крови | 7 | 8 | 01-06-2026 |
| 9 | Team discovers metabolic pathway in cell nucleus that helps cancer progress | 5 | 8 | 08-07-2026 |
| 10 | Новый препарат от рака на основе клеточных средств иммуннотерапии создают в Сибири | 0 | 0 | 09-10-2018 |